World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
31583
World Ranking
14939
National Ranking
581

Overview

Vittorina Zagonel is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research predominantly spans the field of Medicine, with a specialized focus on Oncology and related subfields including Pulmonary and Respiratory Medicine, Genetics, Cancer Research, and Surgery.

Their work has extensively addressed topics such as Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics, Radiomics and Machine Learning in Medical Imaging, and Renal Cell Carcinoma Treatment.

The following are some of their recent publications:

  • Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial, 2023, The Lancet Oncology
  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial, 2020, The Lancet Oncology
  • Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives, 2020, Cancers
  • Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial, 2020, ESMO Open
  • Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases, 2021, JCO Precision Oncology

Vittorina Zagonel has collaborated frequently with several researchers, including:

  • Giuseppe Lombardi
  • Sara Lonardi
  • Mario Caccese
  • Marta Padovan
  • Francesca Bergamo

Their research appears regularly in prominent venues, with noteworthy publication counts in the following journals:

  • Journal of Clinical Oncology
  • Cancers
  • Annals of Oncology
  • Neuro-Oncology
  • European Journal of Cancer

Best Publications

  • Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.

    Andrew X Zhu;Richard S Finn;Julien Edeline;Stephane Cattan

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Comprehensive Geriatric Assessment Adds Information to Eastern Cooperative Oncology Group Performance Status in Elderly Cancer Patients: An Italian Group for Geriatric Oncology Study

    Lazzaro Repetto;Lucia Fratino;Riccardo A. Audisio;Antonella Venturino

  • Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

    Fotios Loupakis;Chiara Cremolini;Gianluca Masi;Sara Lonardi

  • Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): A proof-of-concept, multicentre, open-label, phase 2 trial

    Andrea Sartore-Bianchi;Livio Trusolino;Cosimo Martino;Katia Bencardino

  • ALK+ Lymphoma: Clinico-Pathological Findings and Outcome

    Brunangelo Falini;Stefano Pileri;Pier Luigi Zinzani;Antonino Carbone

  • Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study

    Maurizio Muscaritoli;Simone Lucia;Alessio Farcomeni;Vito Lorusso

  • Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

    Vincenzo Mazzaferro;Bassel F El-Rayes;Michele Droz Dit Busset;Christian Cotsoglou

  • Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

    Manel Esteller;Manel Esteller;Gianluca Gaidano;Steven N. Goodman;Vittorina Zagonel

  • Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

    Giuseppe Lombardi;Gian Luca De Salvo;Alba Ariela Brandes;Marica Eoli

  • Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

    Lorenza Rimassa;Eric Assenat;Markus Peck-Radosavljevic;Marc Pracht

  • CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group

    U Tirelli;D Errante;M Van Glabbeke;I Teodorovic

  • Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

    Emanuele Valtorta;Cosimo Martino;Andrea Sartore-Bianchi;Frédérique Penaullt-Llorca

  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

    Chiara Cremolini;Carlotta Antoniotti;Daniele Rossini;Sara Lonardi

  • Characterization of Overt B-Cell Lymphomas in Patients With Hepatitis C Virus Infection

    Salvatore De Vita;Cosimo Sacco;Domenico Sansonno;Annunziata Gloghini

  • Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

    L. Burt Nabors;Karen L. Fink;Tom Mikkelsen;Danica Grujicic

  • Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

    Daniela Capello;Umberto Vitolo;Laura Pasqualucci;Silvia Quattrone

  • Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions

    Antonino Carbone;Annunziata Gloghini;Emanuela Vaccher;Vittorina Zagonel

  • Gender medicine: a task for the third millennium.

    Giovannella Baggio;Alberto Corsini;Annarosa Floreani;Sandro Giannini

  • Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.

    A Carbone;A Gloghini;V Gattei;D Aldinucci

Frequent Co-Authors

Sara Lonardi
Sara Lonardi Istituto Oncologico Veneto
Fotios Loupakis
Fotios Loupakis Istituto Oncologico Veneto
Umberto Tirelli
Umberto Tirelli National Institutes of Health
Matteo Fassan
Matteo Fassan University of Padua
Alfredo Falcone
Alfredo Falcone University of Pisa
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
Antonino Carbone
Antonino Carbone Centro di Riferimento Oncologico
Andrea Sartore-Bianchi
Andrea Sartore-Bianchi University of Milan
Salvatore Siena
Salvatore Siena University of Milan
Annunziata Gloghini
Annunziata Gloghini University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a career in medicine is varied and can extend far beyond earning an MD. Many students explore alternative healthcare roles, often accessible through flexible online degree options. Popular choices include becoming a nurse practitioner, registered nurse, or advancing as a nurse educator.

For prospective nurse practitioners seeking affordability and flexibility, exploring the cheapest np school options can make this advanced practice role more accessible. Similarly, those interested in foundational nursing roles often search for what is the cheapest online college for nursing? to start their healthcare journey without overwhelming debt.

Experienced nurses looking to take on research, academic, or leadership positions may consider phd nursing programs online, which can allow them to pursue their goals while maintaining their current roles. Likewise, registered nurses aiming for career advancement or higher salaries can benefit from the cheapest accredited online rn to bsn programs.

Online learning provides flexibility and cost-effective solutions for those dedicated to a healthcare career. Exploring these pathways can help you tailor your medical journey to match your personal and professional goals.

Best Scientists Citing Vittorina Zagonel

Trending Scientists